American Cancer Society (2016) Cancer treatment & survivorship facts & figures 2016–2017.
DeSantis C, Ma J, Bryan L, et al. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62. https://doi.org/10.3322/caac.21203.
Wright JL, Reis IM, Zhao W, et al. Racial disparity in estrogen receptor positive breast cancer patients receiving trimodality therapy. Breast. 2012;21:276–83. https://doi.org/10.1016/j.breast.2011.11.003.
Ashley EA. The precision medicine initiative: a new national effort. JAMA. 2015;313:2119–20. https://doi.org/10.1001/jama.2015.3595.
McVeigh TP, Kerin MJ. Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer. Breast Cancer (Dove Med Press). 2017;9:393–400. https://doi.org/10.2147/BCTT.S109847.
National Cancer Institute (2015) Precision medicine initiative and cancer research.
Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344:783–92. https://doi.org/10.1056/NEJM200103153441101.
Keenan T, Moy B, Mroz EA, et al. Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence. J Clin Oncol. 2015;33:3621–7. https://doi.org/10.1200/JCO.2015.62.2126.
Bast RC Jr, Hortobagyi GN. Individualized care for patients with cancer—a work in progress. N Engl J Med. 2004;351:2865–7.
Ramirez J, Elmofty M, Castillo E, et al. Evaluation of cortisol and telomere length measurements in ethnically diverse women with breast cancer using culturally sensitive methods. J Community Genet. 2017;8:75–86. https://doi.org/10.1007/s12687-016-0288-y.
Khoury MJ, Yang Q, Gwinn M, et al. An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med. 2004;6:38–47. https://doi.org/10.1097/01.GIM.0000105751.71430.79.
Roselli M, Ferroni P, Riondino S, et al. Functional impairment of activated protein C in breast cancer—relationship to survival outcomes. Am J Cancer Res. 2016;6:1450–7.
Henry NL, Bedard PL, DeMichele A. Standard and genomic tools for decision support in breast cancer treatment. Am Soc Clin Oncol Educ Book. 2017;37:106–15. 10.14694/EDBK_175617.
Jones T, Lockhart JS, Mendelsohn-Victor KE, et al. Use of cancer genetics services in African-American young breast cancer survivors. Am J Prev Med. 2016;51:427–36. https://doi.org/10.1016/j.amepre.2016.03.016.
Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112:228–42. https://doi.org/10.1002/cncr.23157.
Scott EA, Schlumpf KS, Mathew SM, et al. Biospecimen repositories: are blood donors willing to participate? Transfusion. 2010;50:1943–50.
Levy DE, Byfield SD, Comstock CB, et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011;13:349–55. https://doi.org/10.1097/GIM.0b013e3182091ba4.
Kwiatkowski K, Coe K, Bailar JC, et al. Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved? Cancer. 2013;119:2956–63. https://doi.org/10.1002/cncr.28168.
Dash C, Wallington SF, Muthra S, et al. Disparities in knowledge and willingness to donate research biospecimens: a mixed-methods study in an underserved urban community. J Community Genet. 2014;5:329–36. https://doi.org/10.1007/s12687-014-0187-z.
McDonald JA, Weathers B, Barg FK, Troxel AB, Shea JA, Bowen HCH. Provision intentions for cancer genetics research among African Americans. Genetic testing and molecular biomarkers. 2012;16(4):252–8.
Loffredo CA, Luta G, Wallington S, et al. Knowledge and willingness to provide research biospecimens among foreign-born Latinos using safety-net clinics. J Community Health. 2013;38:652–9. https://doi.org/10.1007/s10900-013-9660-6.
Hagiwara N, Berry-Bobovski L, Francis C, et al. Unexpected findings in the exploration of African American underrepresentation in biospecimen collection and biobanks. J Cancer Educ. 2014;29:580–7. https://doi.org/10.1007/s13187-013-0586-6.
Adams-Campbell LL, Dash C, Palmer JR, et al. Predictors of biospecimen donation in the black women’s health study. Cancer Causes Control. 2016;27:797–803. https://doi.org/10.1007/s10552-016-0747-0.
Morrison DG, Farah C, Hock JM. Informed consent for biobanking research: cancer patient recruitment from rural communities in Maine. Biopreserv Biobank. 2013;11:107–14. https://doi.org/10.1089/bio.2012.0054.
Kwan PP, Briand G, Lee C, et al. Use of a community-based participatory research approach to assess knowledge, attitudes, and beliefs on biospecimen research among Pacific Islanders. Health Promot Pract. 2014;15:422–30. https://doi.org/10.1177/1524839913516464.
Drake BF, Boyd D, Carter K, et al. Barriers and strategies to participation in tissue research among African-American men. J Cancer Educ. 2017;32:51–8. https://doi.org/10.1007/s13187-015-0905-1.
Dang JH, Rodriguez EM, Luque JS, et al. Engaging diverse populations about biospecimen donation for cancer research. J Community Genet. 2014;5:313–27. https://doi.org/10.1007/s12687-014-0186-0.
Tong EK, Fung LC, Stewart SL, et al. Impact of a biospecimen collection seminar on willingness to donate biospecimens among Chinese Americans: results from a randomized, controlled community-based trial. Cancer Epidemiol Biomark Prev. 2014;23:392–401. https://doi.org/10.1158/1055-9965.EPI-13-0744.
Braun KL, Tsark JU, Powers A, et al. Cancer patient perceptions about biobanking and preferred timing of consent. Biopreserv Biobank. 2014;12:106–12. https://doi.org/10.1089/bio.2013.0083.
Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol. 1997;15:974–86.
GN M, RD H (1994) The patient satisfaction questionnaire short-form (PSQ-18), P-7865.
LaVeist TA, Isaac LA, Williams KP. Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res. 2009;44:2093–105.
Roth AJ, Kornblith AB, Batel-Copel L, et al. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82:1904–8. https://doi.org/10.1002/(SICI)1097-0142(19980515)82:103.0.CO;2-X.
Venetis MK, Robinson JD, Turkiewicz KL, et al. An evidence base for patient-centered cancer care: a meta-analysis of studies of observed communication between cancer specialists and their patients. Patient Educ Couns. 2009;77:379–83. https://doi.org/10.1016/j.pec.2009.09.015.
Sheppard VB, Wallington SF, Wiley S, et al. A peer-led decision support intervention improves decision outcomes in black women with breast cancer. J Cancer Educ. 2013;28:262–9.
Eggly S, Barton E, Winckles A, et al. A disparity of words: racial differences in oncologist-patient communication about clinical trials. Health Expect. 2015;18:1316–26. https://doi.org/10.1111/hex.12108.
Byrd GS, Edwards CL, Kelkar VA, et al. Recruiting intergenerational African American males for biomedical research studies: a major research challenge. J Natl Med Assoc. 2011;103:480–7.
Kiviniemi MT, Saad-Harfouche FG, Ciupak GL, et al. Pilot intervention outcomes of an educational program for biospecimen research participation. J Cancer Educ. 2013;28:52–9.
Dash C, Wallington S, Muthra S, et al. Disparities in knowledge and willingness to donate research biospecimens: a mixed-methods study in an underserved urban community. J Community Genet. 2014 Oct;5:329–36.
Partridge EE. Yes, minority and underserved populations will participate in biospecimen collection. Cancer Epidemiol Biomark Prev. 2014;23:895–7. https://doi.org/10.1158/1055-9965.EPI-14-0018.
Townsend CK, Dillard A, Hosoda KK, et al. Community-based participatory research integrates behavioral and biological research to achieve health equity for native Hawaiians. Int J Environ Res Public Health. 2015;13:ijerph13010004. https://doi.org/10.3390/ijerph13010004.